Steven Paladino
Executive Vice President, Chief Financial Officer,
Organisation
Henry Schein Inc?
Portugal
Biography
Mr. Paladino has held the position of Executive Vice President and Chief Financial Officer at Henry Schein since 2000, and has been Chief Financial Officer since 1993. From 1990 to 1992, he served as Vice President and Treasurer, and from 1987 to 1990, served as Corporate Controller. A certified public accountant, he was with BDO Seidman, LLP as Manager, General Audit and Consulting Services prior to joining Henry Schein in 1987. Mr. Paladino's responsibilities include corporate oversight of business units as well as direct responsibility for Corporate Finance. These corporate services include Financial Reporting, Financial Planning, Treasury, Investor Relations, Internal Audit, Risk Management, and Taxation. He also has responsibility for Henry Schein Financial Services, which provides financial business services to Henry Schein's customers and works with the Corporate Business Development Group on Mergers and Acquisition activities. Mr. Paladino led the Company through the corporate reorganization and separation from Schein Pharmaceutical in 1993 and through the IPO process in 1995. He has been a Member of the Board of Directors of Henry Schein, Inc. since 1994 and a Member of the Executive Management Committee 1992. Mr. Paladino is also a member of the American Institute of CPAs, NYS Society of CPAs and the Institute of Management Accountants. Mr. Paladino serves as Board Member for MSC Industrial Supply Co and is a member of its audit committee and compensation committee. He also served as a Nasdaq Listing and Hearing Review Council member. The Listing and Hearing Review Council provides advice to the Board of Directors of The Nasdaq Stock Market LLC on issues relating to listing rule and policy changes and enhancements that will protect investors and the integrity of the Nasdaq Stock Market, while ensuring the consistent and fair application and enforcement of the listing rules, procedures and policies of Nasdaq.
Research Interest
Anasthesia